OncoProAI: The Oncological Support System
Keywords: (Patient) Decision Support System, Artificial Intelligence (AI), Cancer, Digital Health Innovation, Treatment
Short description
Our Flanders-based company proudly presents the Oncological Support System (OncoProAI), an innovative software platform poised to redefine oncological care worldwide through the integration of cutting-edge artificial intelligence (AI) technology. OncoProAI is a personalized cancer treatment decision support software. A smart software that assists oncologists to make most effective, patient specific cancer treatment decision according to latest international guideline in a minute.
As a unique tool, the software will guide doctors in oncology disciplines step by step to make accurate decisions for diagnosing and preparing the treatment plans according to the latest international guidelines such as FDA, EMA, ESMO, and others. The algorithm relies on about 23 years of continuous data collection and research.
OncoProAI not only benefits doctors in making reliable and accurate decisions about each individual patient in a few minutes but also helps to avoid any misdiagnosis and mistreatment. This will not only lead to effective patient management but also reduce the huge treatment cost on society by providing accurate and targeted treatment suggestions.
Evidence
Impact on health outcomes, Economic value to health and care systems, Economic value to patients, Impact on the health system’s capacity and resilience (e.g., health and care efficiency, continuity of care), Contribution to citizen empowerment
By enabling oncologists to make accurate and personalized treatment decisions efficiently, OncoProAI can lead to significant cost savings in the healthcare system. Avoiding misdiagnoses and ineffective treatments can reduce overall healthcare costs, benefiting both healthcare providers and patients.
Maturity
The practice/case/tool is “on the market” and integrated in routine use. There is proven market impact in terms of job creation/spin-off creation or other company growth
Over past twenty years, we have developed our database and the preliminary software which is designed using FreeMind mapping software platform. Our current aim is to develop a new unique, user-friendly platform that enhances clinical decision-making empowered by AI and streamlines workflows on a commercial level.
Countries
Belgium
Germany
Germany
Geographical scope
Local
Practically the software can be used worldside.
Language(s)
Current language is in German and we aredeveloping the English version at the moment.
Comment
The initial target is to cover the oncology market which is consist of over one million doctors from different dissiplins
Submitted in other database or repository of digital health resources that is publicly available
Not Yet but we will submit for grant application from VLAIO
Additional information
Relations
to clinicians / care practitioners
Clinical decision support
Health data analytics (Artificial Intelligence/algorithm development and calibration/machine learning/risk stratification tools/etc.)
Care pathway tracking and adherence
Clinical team care planning and collaboration tools (e.g. digital shared care plan)
Alerting systems for abnormal test results
ICT support for management of frailty and/or falls prevention
Health data analytics (Artificial Intelligence/algorithm development and calibration/machine learning/risk stratification tools/etc.)
Care pathway tracking and adherence
Clinical team care planning and collaboration tools (e.g. digital shared care plan)
Alerting systems for abnormal test results
ICT support for management of frailty and/or falls prevention
to patients / citizens
Health data analytics (Artificial Intelligence/algorithm development and calibration/machine learning/risk stratification tools/etc.)
Digital tools to support health education (health literacy)/digital health literacy
Digital tools to support health education (health literacy)/digital health literacy
Primary target patient group (age)
May be used across all patient ages
Addressed prevention area(s)
Health screenings, Other (please specify below)
Patients subjected to Oncological diagnosis and treatments
Use case and care pathway positioning
Treatment, Early detection and early diagnosis, precision diagnosis
Our cloud base program will be available worldwide for any interested healthcare professionals and educational institutions and universities.
Ready to be transferred to
Ready for transfer, but the practice has not been transferred yet.
Plans for cross-border implementation
Implemented and deployed cross-border
Connectivity of the solution with regional and/or national services
Our cloud base program will be available worldwide for any interested healthcare professionals and educational institutions and universities.